Select Page
Vaccine Considerations Project

Mission

The Vaccine Considerations Project has been created to highlight health and safety throughout the COVID-19 vaccine evaluation process.

Connect with Us at:

 

team@VaccineConsiderations.com

We protect your privacy. We don't share your information.

Feb. 26th FDA Advisory Council (VRBPAC) Meeting

The FDA Vaccines and Related Biological Products Advisory Committee will meet on February 26th to consider the Emergency Use Authorization of the Johnson & Johnson (Janssen Biotech) COVID-19 vaccine.

Presentation #2

The Vaccine Considerations Project’s founder, Jared Krupnick, will provide an oral presentation entitled “Preventing Health Inequities” at the FDA Vaccines and Related Biological Products Advisory Committee meeting on February 26th.

This will be Jared’s second time presenting to the VRBPAC, having also presented when the Committee considered the Pfizer vaccine on December 10th.

 

Dec. 17th FDA Advisory Council (VRBPAC) Meeting

Our Senior Medical Advisor, Dr. David Berger, again, provided an oral presentation at the FDA Vaccines and Related Biological Products Advisory Committee meeting at on December 17th – see the video.

Dec. 10th FDA Advisory Council (VRBPAC) Meeting

Both Jared Krupnick, the Founder of the Vaccine Considerations Project, as well as Board Certified Pediatrician, and the project’s Senior Medical Advisor, Dr. David Berger, were pleased to provide separate oral presentations (Jared’s presentation) (Dr. Berger’s presentation) to the FDA Vaccines and Related Biological Products Advisory Committee meeting on December 10th.

 

Leading the 6pm News in Miami / Ft. Lauderdale

See the very supportive news coverage we received of our presentations to the FDA Advisory Committee December 10th.

WSVN news coverage of Vaccine Considerations Project presentations to the FDA Advisory Committee on Dec. 10, 2020

Dr. Berger Prominently Featured in Tampa Media

See the excellent news coverage our Senior Medical Advisor, Dr. Berger, received of his presentations to the FDA Advisory Committee December 10th (WFLA coverage) (WTSP coverage).

WFLA news coverage of Vaccine Considerations Project presentation to the FDA Advisory Committee on Dec. 10, 2020

 

WTSP news coverage of Vaccine Considerations Project presentation to the FDA Advisory Committee on Dec. 10, 2020

Vision

We’re working to make sure that all health and safety concerns are given due consideration.

We’re creating a repository of information for everyone contemplating getting a vaccine, and for those advising them, that comprehensively addresses health concerns and considerations.

Photo by Kon Karampelas from Pixabay

Public Trust is Necessary

In order to eliminate COVID-19, a large percentage of people need to develop immunity.

Significant vaccine hesitancy has been well documented, and reinforced by recent news.

Widespread concerns must be adequately addressed in order to ensure sufficient buy-in by:

  • public health experts
  • medical professionals
  • the public
Pew Vaccine Survey
Kaiser Family Foundation Poll
FDA Chief Under Pressure
Kaiser Family Foundation Poll
Political Influence on CDC
Pfizer CEO Cashed Out

JAMA - COVID-19 Vaccine Approval and the FDA

Joshua Sharfstein, MD, Johns Hopkins Bloomberg School of Public Health, and JAMA Associate Editor Preeti Malani, MD, University of Michigan, discuss implications for public health and policy responses to ensure vaccine safety.

Additional Considerations

There may be unforeseen adverse reactions for the COVID vaccines that may emerge in people who have:

  • hyperinflammatory conditions
  • cancers
  • people with poor health or nutrition
  • past exposure/immunity to the COVID virus

The Stakes are High

With a high percentage of COVID-19 immunity amongst the population, we may return to a semblance of normalcy within a year or two.

If public trust is broken by an approved vaccine that develops health or safety concerns after being administered to millions of people, many people likely wouldn’t give a second chance to another vaccine.

Without widespread immunity, we could all be forced to live in a world upended by the community spread of COVID-19 for years to come.

The Vaccine Considerations Project

Organizing Collective Concerns

The Vaccine Considerations Project is consolidating, organizing, and amplifying collective COVID-19 vaccine health and safety concerns of:

  • the medical community
  • epidemiologists
  • public health experts
  • the community at large
Vaccine Considerations Project Matrix of Concerns
Vaccine Considerations Project Logic Model

Repository of Information

We’re making our repository of information available to:

  • advisory panels
  • national associations
  • medical professionals
  • researchers
  • individuals
  • the media

Photo by Kon Karampelas from Pixabay

Collective Action Required

We’re urging all concerned stakeholders to collectively contribute to, and share, a comprehensive repository of information that addresses health and safety concerns for the COVID vaccines.

It’s imperative that we urgently work together to ensure that any approved vaccine is safe.

All Hands on Deck

We’re recruiting all that align with this critical project.

Contribute your time and skills to help prevent catastrophic health conditions from arising.

See the positions we’re filling, and apply for an internship or position on our interdisciplinary team of students and professionals.